Supreme Court Rules Against Zicam Maker New York Times WASHINGTON — The Supreme Court unanimously ruled on Tuesday that investors suing a drug company for securities fraud may rely on its failure to disclose scattered reports of adverse affects from an over-the-counter cold remedy that fell ... |
No comments:
Post a Comment